How can you slow down the progression of brain degeneration that comes with PD? What are some protective strategies that you can employ to protect your brain health? Along with known measures like exercise, nutrition and various therapies, what are some current and emerging options with clinical trials or preclinical trials?
Watch as we chat with Dr. Stanley Fahn, one of the founding fathers of the Movement Disorders Society, about the diverse mechanisms that are involved in PD, as well as therapies and strategies that can be implemented to prevent PD from progressing at a rapid rate.
This interview-style webinar is a part of Skypass Foundation's "Ask the Doctor" series and was hosted live on Zoom on January 19, 2021. For more information on this webinar series, please visit www.skypassfoundation.org/askthedoctor
ABOUT OUR GUEST
Stanley Fahn, MD is the H. Houston Merritt Professor Emeritus of Neurology and Director Emeritus of the Center for Parkinson’s Disease and Other Movement Disorders at Columbia University Medical Center in New York. He retired from Columbia on Jan 1, 2021, after 57 years of teaching, research and patient care. His major research interest has been in experimental therapeutics, and he has participated in many clinical trials, especially in Parkinson disease (PD). In 1985, he co-founded with Dr. David Marsden The Movement Disorder Society and was elected its first president.
Dr. Fahn has earned several awards, including the Wartenberg Award for outstanding clinical research from the American Academy of Neurology, and the Jay Van Andel Award for Outstanding Achievement in Parkinson's Disease Research from the Van Andel Research Institute. Dr. Fahn has trained over 130 movement disorder fellows, including many who are professors of neurology around the globe.
